loader

World Tenders & Procurement Opportunities

Awarded - 367392 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient bexarotene, ATC L01XF03, for the period 01.06.2024 - 31.05.2026

World Biggest Tenders Source

This tender with title Awarded - 367392 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient bexarotene, ATC L01XF03, for the period 01.06.2024 - 31.05.2026 has been published on Bidding Source portal dated 01 Jun 2026 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Awarded - 367392 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient bexarotene, ATC L01XF03, for the period 01.06.2024 - 31.05.2026
Contract Award
367392
Germany
1 Jun 2026
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Awarded - 367481 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient clobazam, ATC N05BA09, for the period 01.03.2025 - 28.02.2027 Germany Awarded - 368231 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient diclofenac (exclusively GEL 25 g), ATC D11AX18 for the period 01.04.2025 - 31.03.2027 Germany Awarded - 367847 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient Ganirelix, ATC H01CC01, for the period 01.06.2024 - 31.05.2026 Germany Awarded - 133782- Germany – Pharmaceutical products – Announcement of awarded contracts pursuant to Section 130c of the German Social Code, Book V (SGB V) for the medicinal product Metformin / Dapagliflozin (Xigduo) Germany 133159- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-34 - Eculizumab Germany 133422- Germany – Pharmaceutical products – Open-House-Biologics-Rebate Agreements 2026-03b - Eculizumab (incl. the indication gMG and NMOSD) Germany 132076- Germany – Pharmaceutical products – Open-House-Biologics-Rebate Agreements 2026-03a - Eculizumab (excluding the indication gMG and NMOSD) Germany Awarded - 131852- Germany – Pharmaceutical products – Announcement of awarded contracts pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient Tegomil fumarate (Riulvy) Germany Awarded - 131795- Germany – Pharmaceutical products – Announcement of awarded contracts pursuant to Section 130c of the German Social Code, Book V (SGB V) for the medicinal product Inclisiran (Leqvio) Germany 126159- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient nintedanib (ATC code: L01EX09). Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans